Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
JD.1.2.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JD.1.2.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.268ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.268ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.268ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.268NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.409ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.409ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.409ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.409NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
FG.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
FG.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
FG.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FG.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
KV.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
KV.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
KV.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
KV.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
GK.1.6ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
GK.1.6ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
GK.1.6ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
GK.1.6NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BA.5.2.31ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BA.5.2.31ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.5.2.31ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.5.2.31NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.587ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.587ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.587ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.587NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.232ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.232ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.232ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.232NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BA.5.2.60ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BA.5.2.60ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.5.2.60ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.5.2.60NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
CD.2ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
CD.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
CD.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
CD.2NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
CM.4.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
CM.4.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
CM.4.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
CM.4.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BA.5.1.7ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BA.5.1.7ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.5.1.7ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.5.1.7NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used